Vg Life Sciences Stock Retained Earnings
| VGLS Stock | USD 0.0001 0.00 0.00% |
Vg Life Sciences fundamentals help investors to digest information that contributes to Vg Life's financial success or failures. It also enables traders to predict the movement of VGLS Pink Sheet. The fundamental analysis module provides a way to measure Vg Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vg Life pink sheet.
VGLS |
Vg Life Sciences Company Retained Earnings Analysis
Vg Life's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Vg Life Retained Earnings | (109.84 M) |
Most of Vg Life's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vg Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
| Competition |
Based on the latest financial disclosure, Vg Life Sciences has a Retained Earnings of (109.84 Million). This is 111.79% lower than that of the Biotechnology sector and 213.36% lower than that of the Health Care industry. The retained earnings for all United States stocks is 101.18% higher than that of the company.
VGLS Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vg Life's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Vg Life could also be used in its relative valuation, which is a method of valuing Vg Life by comparing valuation metrics of similar companies.Vg Life is currently under evaluation in retained earnings category among its peers.
VGLS Fundamentals
| Return On Asset | -1.51 | |||
| Current Valuation | 4.44 M | |||
| Shares Outstanding | 107.88 M | |||
| Price To Earning | (0.14) X | |||
| Price To Book | 32.38 X | |||
| EBITDA | (3.43 M) | |||
| Net Income | (6.19 M) | |||
| Cash And Equivalents | 22.92 K | |||
| Total Debt | 3.38 M | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | (0.05) X | |||
| Cash Flow From Operations | (1.91 M) | |||
| Earnings Per Share | (0.07) X | |||
| Target Price | 0.15 | |||
| Beta | 2.76 | |||
| Market Capitalization | 1.82 M | |||
| Total Asset | 1.32 M | |||
| Retained Earnings | (109.84 M) | |||
| Working Capital | (5.42 M) | |||
| Current Asset | 40 K | |||
| Current Liabilities | 5.46 M | |||
| Net Asset | 1.32 M |
About Vg Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vg Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vg Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vg Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for VGLS Pink Sheet Analysis
When running Vg Life's price analysis, check to measure Vg Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vg Life is operating at the current time. Most of Vg Life's value examination focuses on studying past and present price action to predict the probability of Vg Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vg Life's price. Additionally, you may evaluate how the addition of Vg Life to your portfolios can decrease your overall portfolio volatility.